Delivery Order SPE2DB22D3501-SPE2DB25FVZ30

Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,515.01 firm-fixed-price contract is for the supply of Phenylephrine 10 mg/mL vials. The contract has a period of performance through May 21, 2024 and was awarded on May 20, 2022. This delivery order is placed against Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,129.61 firm-fixed-price delivery order is for the supply of Phenylephrine 10 mg/ml vials. The contract has an ultimate completion date of May 30, 2025 and was awarded on May 29, 2025. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Phenylephrine Hydrochloride, a pharmaceutical product, with a ceiling value of $4,197.60 and a period of performance through June 13, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,166.35, is a delivery order for the supply of Phenylephrine 10 mg/ml vial, a medical product. The contract has an ultimate completion date of March 27, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. The contract is not a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a delivery order valued at $2,057.53, with a firm fixed price pricing type and an ultimate completion date of May 23, 2025. The contract is for the supply of Phenylephrine Hydrochloride, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $4,197.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Phenylephrine 10 mg/ml vials, a medical product used for various medical applications. The award is a Firm Fixed Price Delivery Order contract that runs through January 24, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The $1,224.30 firm fixed price delivery order is for the supply of PHENYLEPHRINE HYDROCH, a pharmaceutical product, with a performance period through June 18, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of PHENYLEPHRINE HYDROCH, a medical supply, to the Defense Logistics Agency (DLA), a part of the U.S. Department of Defense. The contract, valued at $2,872.80, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Firm Fixed Price Delivery Order with a completion date of May 27, 2025. It is not designated as a set-aside contract,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Phenylephrine 2.5% Eye Drops in 15 milliliter quantities, with a ceiling value of $1,127.26 and a period of performance through June 6, 2025. The contract is a firm-fixed-price delivery order and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,098.82, is for the supply of Phenylephrine 2.5% eye drops with a completion date of January 21, 2025. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVZ30
    Delivery Order

This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Phenylephrine 10 mg/mL medication vials, with a ceiling value of $2,229.67 and a completion date of June 11, 2025. The contract is a Firm Fixed Price type, with no set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/14/25, 12:59 AM